We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
SemBioSys and Tasly Pharmaceutical to Participate in the 5th CCBF and Signing Ceremony
News

SemBioSys and Tasly Pharmaceutical to Participate in the 5th CCBF and Signing Ceremony

SemBioSys and Tasly Pharmaceutical to Participate in the 5th CCBF and Signing Ceremony
News

SemBioSys and Tasly Pharmaceutical to Participate in the 5th CCBF and Signing Ceremony

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "SemBioSys and Tasly Pharmaceutical to Participate in the 5th CCBF and Signing Ceremony"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

SemBioSys Genetics Inc. has announced that it will be present at the 5th Canada-China Business Forum (CCBF) and Signing Ceremony on February 9, 2012, in Beijing, China.

SemBioSys and its Chinese partner, Tasly Pharmaceutical Co., Ltd. are to sign supplementary documents necessary to establish the recently People's Republic of China approved Joint Venture.

The Joint Venture, based in Tianjin, China, called Tasly-SemBioSys Bio-Pharmaceutical Technology Co., Ltd., will commercialize near, medium, and long term healthy living, nutritional, and pharmaceutical products utilizing Tasly and SemBioSys' plant-based technology and expertise.

"The common values and scientific principles we share with Tasly Pharmaceutical and their approach to traditional Chinese medicine and biological drugs made our partnership a natural step in the progression of SemBioSys," said James Szarko, President and CEO of SemBioSys.

Szarko continued, "It is an honour to confirm our agreement at the Signing Ceremony and in the presence of Canada's own Prime Minister Harper."

Advertisement